CMT-TRIAAL Group

Author PubWeight™ 3.30^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27].	Pharmacol Res	2006	0.99
2	Novel outcome measures for Charcot-Marie-Tooth disease: validation and reliability of the 6-min walk test and StepWatch(™) Activity Monitor and identification of the walking features related to higher quality of life.	Eur J Neurol	2016	0.79
3	PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker.	Brain	2014	0.78
4	Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease.	Eur J Neurol	2015	0.76